1241911-27-2

Upstream product

• 589-87-7 1,4-bromoiodobenzene 
• 557-21-1 zinc(II) cyanide 
• 223555-87-1 4-(4-bromophenyl)-3,6-dihydro-2H-pyran 
• 29943-42-8 Tetrahydro-4H-pyran-4-one 
• 623-00-7 4-bromobenzenecarbonitrile 
• 126747-14-6 4-cyanophenylboronic acid 
• 188975-30-6 5,6-dihydro-4-trifluoromethylsulfonyloxy-2H-pyran 
• 1085453-54-8 4-(4-hydroxytetrahydro-2H-pyran-4-yl)benzenecarbonitrile 

Downstream Products

• 1227159-78-5 4-(tetrahydro-2H-pyran-4-yl)benzonitrile 
• 1241911-28-3 (4-(tetrahydro-2H-pyran-4-yl)phenyl)methanamine 
• 1247826-76-1 4-(3,6-dihydro-2H-pyran-4-yl)benzoic acid 

Relevant academic research and scientific papers

ANTI-INFECTIVE COMPOUNDS

The present invention relates to small molecule compounds and their use in the treatment of bacterial infections, in particular Tuberculosis.

NOVEL BRONCHODILATING DIAZAHETEROARYLS

The invention relates to novel compounds having the general formula (I), and which compounds are useful to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma.

Plasminogen Activator Inhibitor-1 Inhibitor

The present invention provides a novel compound having plasminogen activator inhibitor-1 inhibitory activity, and an inhibitor of PAI-1 comprising the compound as an active ingredient. The present invention also provides a pharmaceutical composition having an inhibitory action on PAI-1 activity and being efficacious in the prevention and treatment of various diseases whose onset is associated with PAI-1 activity.

NOVEL BRONCHODILATING DIAZAHETEROARYLS

The invention relates to novel compounds having the general formula (I), and which compounds are useful to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma.